我要投票 以岭药业在中草药行业中的票数:231
· 外 推 电 报 ·
2025-05-04 15:41:00 星期日

【以岭药业是哪个国家的品牌?】

以岭药业是什么牌子?「以岭药业」是 石家庄以岭药业股份有限公司 旗下著名品牌。该品牌发源于河北,由创始人吴相君在2001期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力以岭药业品牌出海!将品牌入驻外推网,定制以岭药业品牌推广信息,可以显著提高以岭药业产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

国家重点高新技术企业--石家庄以岭药业股份有限公司由中国工程院吴以岭院士创建,在他的领导下,以岭药业始终坚持以科技为先导,以市场为龙头的科技创新发展战略,创立"理论-科研-新药-生产-营销"五位一体的独特运营模式,建立起以中医络病理论创新为指导的新药研发创新技术体系。

在以岭药业的发展历程中,凝聚了一大批科研、管理、生产、营销精英,包括归国专家、外籍专家、博士、硕士及各类高职人才,为河北医科大学培养博士、硕士研究生,被国家人事部批准为博士后科研工作站。

以岭药业以络病理论创新带动中医药产业化,运用现代高新技术研发现代中药、西药、和生物药,研发国家专利新药9个,覆盖心脑血管疾病、感冒呼吸疾病、肿瘤、糖尿病及其并发症等重大疾病领域。通过国家GMP认证的中药生产线、通过欧盟认证的化学制剂生产车间具有年产值达50亿的生产能力。以岭药业为国家创新型企业、中国制药工业50强,以岭商标成为中国驰名商标。

国家科技部前领导曾赞誉五位一体的发展模式为"我国中医药科技成果产业化的创举"。

以岭药业立足国内、接轨国际,在石家庄、北京大兴、密云建立了三个国际标准的科研生产基地,通过了欧盟、新西兰等GMP认证。科研、生产、质检、贸易、管理人才全部具有国际化背景,构建了符合国际药品标准的生产、质控体系。依靠现代高新技术与设备和完善的药品生产质量控制体系,生产高品质中药与西药。产品已经出口到英国、美国、西班牙、韩国、日本、俄罗斯、新西兰等许多国家。

位于北京生物工程与医药产业基地的北京以岭药业,占地210亩,为国家重点高新技术企业,主要生产面向国际市场的植物药、保健品、膳食补充剂。

位于北京密云的北京以岭生物按照欧美GMP标准建设,主要生产面向国际市场的激素、肿瘤类药物和具有自主知识产权的新制剂。

英文翻译:Shijiazhuang Yiling Pharmaceutical Co., Ltd, a national key high-tech enterprise, was founded by Academician Wu Yiling of Chinese Academy of engineering. Under his leadership, Yiling pharmaceutical always adheres to the development strategy of scientific and technological innovation with science and technology as the guide and market as the leader, creates a unique operation mode of "theory research new medicine production marketing" and establishes a theoretical innovation of traditional Chinese medicine collateral disease as the reference New drug R & D innovation technology system. In the development process of Yiling pharmaceutical industry, a large number of scientific research, management, production and marketing elites, including returned experts, foreign experts, doctors, masters and all kinds of higher vocational talents, have been gathered, training doctors and masters for Hebei Medical University, and approved by the Ministry of human resources as post doctoral research workstation. Lingyao promotes the industrialization of traditional Chinese medicine with the innovation of collateral disease theory, develops modern Chinese medicine, western medicine and biological medicine with modern high and new technology, and develops 9 new national patent drugs, covering the major disease fields such as cardio cerebrovascular disease, cold and respiratory disease, tumor, diabetes and its complications. The production line of traditional Chinese medicine certified by national GMP and the chemical production workshop certified by European Union have an annual output value of 5 billion. Take Ling pharmaceutical as a national innovative enterprise and top 50 pharmaceutical industry in China, and take Ling trademark as a well-known trademark in China. Former leaders of the Ministry of science and technology of the people's Republic of China once praised the five in one development mode as "the pioneering work of industrialization of scientific and technological achievements of traditional Chinese medicine". Based on domestic and international standards, Yiling pharmaceutical has established three international standard research and production bases in Shijiazhuang, Beijing Daxing and Miyun, and has passed GMP certification of EU, New Zealand, etc. The talents of scientific research, production, quality inspection, trade and management all have international background, and the production and quality control system in line with international drug standards has been established. Relying on modern high-tech and equipment and perfect quality control system of drug production, we can produce high-quality traditional Chinese medicine and Western medicine. The products have been exported to the United Kingdom, the United States, Spain, South Korea, Japan, Russia, New Zealand and many other countries. Located in Beijing bioengineering and pharmaceutical industry base, Beijing Yiling pharmaceutical, covering an area of 210 mu, is a national key high-tech enterprise, which mainly produces plant medicine, health care products and dietary supplements for the international market. Beijing Yiling biology, located in Miyun, Beijing, is built in accordance with European and American GMP standards. It mainly produces hormones, tumor drugs and new preparations with independent intellectual property rights for the international market.

本文链接: https://www.waitui.com/brand/887854f10.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

投票通过,马斯克的星舰基地成了一座“真正的”城镇

美国太空探索技术公司(SpaceX)火箭制造与发射基地所在的得克萨斯州南部墨西哥湾沿岸地区于5月3日投票,决定是否将当地升级为一座名为“星舰基地”的城镇。目前,有173票赞成,4票反对。只需143票赞成就算通过,“星舰基地”成为城镇已成定局。太空探索技术公司首席执行官埃隆·马斯克在社交媒体发文:“得克萨斯的星舰基地,现在是一座真正的城市了!”。太空探索技术公司的火箭制造与发射基地位于得州南部的博卡奇卡,面积仅3.9平方公里,靠近美国与墨西哥边境。公司首席执行官埃隆·马斯克2021年最初提出在此建立城镇的想法。对该投票,太空探索技术公司未予置评,公司高层先前也未解释为何要建立这样一座企业城镇。(央视新闻)

2小时前

全国出行客流持续高位运行,公路迎来返程车流

今天是“五一”假期的第四天,客流继续保持高位运行。公路迎来返程车流。今天全国铁路预计发送旅客2040万人次,计划加开列车1818列。客流较昨日有明显增长,继续保持高位运行。多地增开赏花高铁、夜间高铁等,同时根据客流情况增加人工检票口和进站安检通道,减少旅客的等候时间。公路出行方面,中长途返程车流与短途返城车流叠加,返程高峰显现,预计今天16—18点将出现返程车流量大现象。(央视新闻)

2小时前

天津物美超市学习胖东来自主调改

继天津永辉学习胖东来调改后,物美超市也加入调改队伍。5月1日,物美超市官方正式发布《学习胖东来自主调改的说明》,天津首家调改店定在物美超市北辰店。(今晚报)

2小时前

铁路迎来返程高峰,今日北京地区预计到达旅客75.8万人次

今日铁路迎来返程客流高峰,记者从国铁集团获悉,5月4日,全国铁路预计发送旅客2040万人次,计划加开旅客列车1818列。北京地区预计发送63.4万人次、到达75.8万人次,计划增开旅客列车60对,主要开往上海、武汉、沈阳、济南、青岛、太原、天津、石家庄、张家口等方向。(北京日报)

2小时前

“英伟达已向中国三家企业通报”

据台湾《工商时报》网站5月3日报道,在针对中国市场的H20芯片遭美国政府禁售后,美国芯片大厂英伟达正加紧开发另一款符合美国出口规定的人工智能(AI)芯片,以继续保住其在中国的市场份额。据美媒报道,英伟达已向中国三家企业通报,正调整AI芯片设计,寻求在不触犯美国出口管制的前提下,继续向中国供应产品。(参考消息)

2小时前

本页详细列出关于以岭药业的品牌信息,含品牌所属公司介绍,以岭药业所处行业的品牌地位及优势。
咨询